Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Mar 12;331(10):831-833.
doi: 10.1001/jama.2024.1755.

Treating Attention-Deficit/Hyperactivity Disorder Matters

Frances R Levin  1   2 , Mariely Hernandez  1   2 , John J Mariani  1   2
Affiliations
Editorial

Treating Attention-Deficit/Hyperactivity Disorder Matters

Frances R Levin et al. JAMA. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Li L, Zhu N, Zhang L, et al. ADHD pharmacotherapy and mortality in individuals with ADHD. JAMA. Published March 12, 2024. doi: 10.1001/jama.2024.0851 - DOI - PMC - PubMed
    1. Dalsgaard S, Østergaard SD, Leckman JF, Mortensen PB, Pedersen MG. Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder: a nationwide cohort study. Lancet. 2015;385(9983):2190–2196. doi: 10.1016/S0140-6736(14)61684-6 - DOI - PubMed
    1. Kosheleff AR, Mason O, Jain R, Koch J, Rubin J. Functional impairments associated with ADHD in adulthood and the impact of pharmacological treatment. J Atten Disord. 2023;27(7):669–697. doi: 10.1177/10870547231158572 - DOI - PMC - PubMed
    1. Chang Z, Ghirardi L, Quinn PD, Asherson P, D’Onofrio BM, Larsson H. Risks and benefits of attention-deficit/hyperactivity disorder medication on behavioral and neuropsychiatric outcomes: a qualitative review of pharmacoepidemiology studies using linked prescription databases. Biol Psychiatry. 2019;86(5):335–343. doi: 10.1016/j.biopsych.2019.04.009 - DOI - PMC - PubMed
    1. Kast KA, Rao V, Wilens TE. Pharmacotherapy for attention-deficit/hyperactivity disorder and retention in outpatient substance use disorder treatment: a retrospective cohort study. J Clin Psychiatry. 2021;82(2):20m13598. doi: 10.4088/JCP.20m13598 - DOI - PMC - PubMed

MeSH terms